Medical Director, Hematology Clinical Development

Disc Medicine; Massachusetts; Hybrid; USD 220,000 - 360,000; Full time

Job summary

Disc Medicine in Massachusetts seeks a Medical Director for Clinical Development to provide medical and scientific leadership on clinical trials targeting iron metabolism and hematologic diseases. The role involves designing clinical programs, overseeing studies, and collaborating across cross-functional teams in a hybrid position based in Massachusetts.

The successful candidate will shape clinical development plans, ensure regulatory alignment, and drive data-driven decisions to advance novel

Qualifications

• Expertise in hematology and/or anemia management.
• Clinical research experience and drug development knowledge.
• Strong understanding of clinical trial design and execution.
• Experience with regulatory documentation and scientific communications.
• Ability to work collaboratively across multiple functional teams.

Responsibilities

• Provide medical leadership for assigned clinical development programs and studies.
• Develop clinical development strategies, study designs, and regulatory documents.
• Serve as Study Physician or Medical Monitor with oversight of safety and data quality.
• Interpret clinical data and emerging evidence to inform program decisions.
• Build relationships with investigators, key opinion leaders, and external experts.

Skills

Hematology expertise

Clinical research experience

Drug development knowledge

Clinical trial design

Regulatory documentation

Scientific communications

Collaborative across teams

Job description

Disc Medicine in Massachusetts seeks a Medical Director for Clinical Development to provide medical and scientific leadership on clinical trials targeting iron metabolism and hematologic diseases. The role involves designing clinical programs, overseeing studies, and collaborating across cross-functional teams in a hybrid position based in Massachusetts.

The successful candidate will shape clinical development plans, ensure regulatory alignment, and drive data-driven decisions to advance novel